{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T00:14:05Z","timestamp":1794701645015,"version":"4.9.1"},"reference-count":137,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472780"],"award-info":[{"award-number":["82472780"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972657"],"award-info":[{"award-number":["81972657"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81830085"],"award-info":[{"award-number":["81830085"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.aohep.2024.101774","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T11:39:27Z","timestamp":1734435567000},"page":"101774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Mechanisms and therapeutic targets of mitochondria in the progression of metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1016","volume":"30","author":[{"given":"Chenyang","family":"Mu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenghan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haozan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2024.101774_bib0001","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review","volume":"32","author":"Chan","year":"2023","journal-title":"J Obes Metab Syndr"},{"key":"10.1016\/j.aohep.2024.101774_bib0002","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2024.101774_bib0003","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2024.101774_bib0004","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/HEP.0000000000000604","article-title":"National prevalence estimates for steatotic liver disease and subclassifications using consensus nomenclature","volume":"79","author":"Lee","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2024.101774_bib0005","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2024.101774_bib0006","first-page":"22","article-title":"MASLD-mimicking microenvironment drives an aggressive phenotype and represses IDH2 expression in hepatocellular carcinoma","volume":"10","author":"Korhan","year":"2024","journal-title":"Hepatoma Res"},{"key":"10.1016\/j.aohep.2024.101774_bib0007","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/ijc.25797","article-title":"Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis","volume":"128","author":"Ertle","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.aohep.2024.101774_bib0008","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD","volume":"35","author":"Miao","year":"2024","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.aohep.2024.101774_bib0009","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.aohep.2024.101774_bib0010","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0006-2952(02)01176-0","article-title":"Cell signalling and the glutathione redox system","volume":"64","author":"Filomeni","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.aohep.2024.101774_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0076-6879(10)73001-9","article-title":"Changing paradigms in thiology from antioxidant defense toward redox regulation","volume":"473","author":"Floh\u00e9","year":"2010","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.aohep.2024.101774_bib0012","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1172\/JCI46069","article-title":"The role of lipid droplets in metabolic disease in rodents and humans","volume":"121","author":"Greenberg","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.aohep.2024.101774_bib0013","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1080\/15548627.2015.1091141","article-title":"ER stress: autophagy induction, inhibition and selection","volume":"11","author":"Rashid","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.aohep.2024.101774_bib0014","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/path.4803","article-title":"Mitochondrial genome architecture in non-alcoholic fatty liver disease","volume":"240","author":"Sookoian","year":"2016","journal-title":"J Pathol"},{"key":"10.1016\/j.aohep.2024.101774_bib0015","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \u201chits\u201d?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2024.101774_bib0016","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.plipres.2012.10.004","article-title":"Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease","volume":"52","author":"Leamy","year":"2013","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.aohep.2024.101774_bib0017","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.aohep.2024.101774_bib0018","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.3748\/wjg.14.2474","article-title":"Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment","volume":"14","author":"Schreuder","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2024.101774_bib0019","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1210\/er.2008-0009","article-title":"Causes and metabolic consequences of Fatty liver","volume":"29","author":"Stefan","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/j.aohep.2024.101774_bib0020","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1172\/JCI34275","article-title":"Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice","volume":"118","author":"Postic","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.aohep.2024.101774_bib0021","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI25102","article-title":"Inflammation, stress, and diabetes","volume":"115","author":"Wellen","year":"2005","journal-title":"J Clin Invest"},{"issue":"Suppl 2","key":"10.1016\/j.aohep.2024.101774_bib0022","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.2337\/diabetes.54.suppl_2.S73","article-title":"Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes","volume":"54","author":"Hotamisligil","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.aohep.2024.101774_bib0023","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/hep.32324","article-title":"Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD","volume":"76","author":"Moore","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2024.101774_bib0024","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.aohep.2024.101774_bib0025","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-immunol-051116-052415","article-title":"Immune Responses in the Liver","volume":"36","author":"Kubes","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.aohep.2024.101774_bib0026","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2009.03.008","article-title":"Kupffer cells in non-alcoholic fatty liver disease: the emerging view","volume":"51","author":"Baffy","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2024.101774_bib0027","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41419-023-05853-6","article-title":"Butyrate limits inflammatory macrophage niche in NASH","volume":"14","author":"Sarkar","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.aohep.2024.101774_bib0028","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1183\/09031936.00023310","article-title":"Role of NF-kappaB and PPAR-gamma in lung inflammation induced by monocyte-derived microparticles","volume":"37","author":"Neri","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.aohep.2024.101774_bib0029","doi-asserted-by":"crossref","first-page":"44612","DOI":"10.1038\/srep44612","article-title":"Effect of modulation of PPAR-\u03b3 activity on Kupffer cells M1\/M2 polarization in the development of non-alcoholic fatty liver disease","volume":"7","author":"Luo","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.aohep.2024.101774_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.660179","article-title":"The role of the gut-liver axis in metabolic dysfunction-associated fatty liver disease","volume":"12","author":"Mart\u00edn-Mateos","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.aohep.2024.101774_bib0031","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/s41591-022-02016-6","article-title":"Microbiome-derived ethanol in nonalcoholic fatty liver disease","volume":"28","author":"Meijnikman","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.aohep.2024.101774_bib0032","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1111\/j.1572-0241.2001.04667.x","article-title":"Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease","volume":"96","author":"Willner","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aohep.2024.101774_bib0033","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s10620-023-08214-7","article-title":"Parental history of Type 2 diabetes mellitus and PNPLA3 polymorphism increase the risk of severe stages of nonalcoholic fatty liver disease","volume":"69","author":"Wajsbrot","year":"2024","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.aohep.2024.101774_bib0034","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1053\/j.gastro.2009.01.050","article-title":"Heritability of nonalcoholic fatty liver disease","volume":"136","author":"Schwimmer","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2024.101774_bib0035","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jhep.2008.12.025","article-title":"Genetic factors contribute to variation in serum alanine aminotransferase activity independent of obesity and alcohol: a study in monozygotic and dizygotic twins","volume":"50","author":"Makkonen","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2024.101774_bib0036","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/hep.23759","article-title":"The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease","volume":"52","author":"Rotman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2024.101774_bib0037","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/hep.23622","article-title":"Homozygosity for the patatin-like phospholipase-3\/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"51","author":"Valenti","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2024.101774_bib0038","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1093\/hmg\/ddp357","article-title":"The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver","volume":"18","author":"Beer","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.aohep.2024.101774_bib0039","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.aohep.2024.101774_bib0040","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jhep.2011.05.029","article-title":"The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies","volume":"56","author":"Al-Serri","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2024.101774_bib0041","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.jhep.2006.12.012","article-title":"The phosphatidylethanolamine N-methyltransferase gene V175M single nucleotide polymorphism confers the susceptibility to NASH in Japanese population","volume":"46","author":"Dong","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2024.101774_bib0042","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1478-3231.2009.01988.x","article-title":"Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease","volume":"29","author":"Yoneda","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2024.101774_bib0043","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1158\/0008-5472.CAN-04-4249","article-title":"A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk","volume":"65","author":"Narla","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.aohep.2024.101774_bib0044","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrgastro.2013.149","article-title":"From NAFLD to NASH to cirrhosis-new insights into disease mechanisms","volume":"10","author":"Wree","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2024.101774_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2019.108319","article-title":"The nonalcoholic fatty liver disease-like phenotype and lowered serum VLDL are associated with decreased expression and DNA hypermethylation of hepatic ApoB in male offspring of ApoE deficient mothers fed a with Western diet","volume":"77","author":"Chen","year":"2020","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.aohep.2024.101774_bib0046","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2337\/db15-1716","article-title":"Hepatic DPP4 DNA methylation associates with fatty liver","volume":"66","author":"Baumeier","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.aohep.2024.101774_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2019.105667","article-title":"Resveratrol alleviates non-alcoholic fatty liver disease through epigenetic modification of the Nrf2 signaling pathway","volume":"119","author":"Hosseini","year":"2020","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.aohep.2024.101774_bib0048","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jhep.2010.03.016","article-title":"Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis","volume":"53","author":"Anstee","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2024.101774_bib0049","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI30542","article-title":"Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ","volume":"117","author":"Iredale","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.aohep.2024.101774_bib0050","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1126\/science.aad7977","article-title":"Sperm tsRNAs contribute to intergenerational inheritance of an acquired metabolic disorder","volume":"351","author":"Chen","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.aohep.2024.101774_bib0051","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0968-0004(00)01609-1","article-title":"The internal structure of mitochondria","volume":"25","author":"Frey","year":"2000","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.aohep.2024.101774_bib0052","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/j.gastro.2018.06.083","article-title":"Mitochondrial dysfunction and signaling in chronic liver diseases","volume":"155","author":"Mansouri","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2024.101774_bib0053","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-pathmechdis-012419-032711","article-title":"Mitochondrial dynamics and its involvement in disease","volume":"15","author":"Chan","year":"2020","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.aohep.2024.101774_bib0054","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1038\/emboj.2009.255","article-title":"Mitochondrial \u201ckiss-and-run\u201d: interplay between mitochondrial motility and fusion-fission dynamics","volume":"28","author":"Liu","year":"2009","journal-title":"EMBO J"},{"key":"10.1016\/j.aohep.2024.101774_bib0055","doi-asserted-by":"crossref","first-page":"R207","DOI":"10.1016\/j.cub.2016.01.009","article-title":"Mitochondrial dynamics: ER actin tightens the Drp1 noose","volume":"26","author":"Prudent","year":"2016","journal-title":"Curr Biol"},{"key":"10.1016\/j.aohep.2024.101774_bib0056","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nature20555","article-title":"Multiple dynamin family members collaborate to drive mitochondrial division","volume":"540","author":"Lee","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.aohep.2024.101774_bib0057","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1126\/science.283.5407.1488","article-title":"Oxidative phosphorylation at the fin de si\u00e8cle","volume":"283","author":"Saraste","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.aohep.2024.101774_bib0058","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/35072063","article-title":"The genetics and pathology of oxidative phosphorylation","volume":"2","author":"Smeitink","year":"2001","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.aohep.2024.101774_bib0059","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/191144a0","article-title":"Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism","volume":"191","author":"Mitchell","year":"1961","journal-title":"Nature"},{"key":"10.1016\/j.aohep.2024.101774_bib0060","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1152\/physrev.00021.2013","article-title":"Mitochondrial channels: ion fluxes and more","volume":"94","author":"Szabo","year":"2014","journal-title":"Physiol Rev"},{"key":"10.1016\/j.aohep.2024.101774_bib0061","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1126\/science.1171091","article-title":"S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury","volume":"324","author":"Cho","year":"2009","journal-title":"Science"},{"issue":"Suppl 2","key":"10.1016\/j.aohep.2024.101774_bib0062","doi-asserted-by":"crossref","first-page":"S513","DOI":"10.3233\/JAD-2010-100552","article-title":"S-Nitrosylation of DRP1 does not affect enzymatic activity and is not specific to Alzheimer's disease","volume":"20","author":"Bossy","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.aohep.2024.101774_bib0063","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.molcel.2012.05.041","article-title":"Stress-induced phosphorylation and proteasomal degradation of mitofusin 2 facilitates mitochondrial fragmentation and apoptosis","volume":"47","author":"Leboucher","year":"2012","journal-title":"Mol Cell"},{"key":"10.1016\/j.aohep.2024.101774_bib0064","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.1093891","article-title":"S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function","volume":"304","author":"Chung","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.aohep.2024.101774_bib0065","first-page":"127","article-title":"Mitochondrial DNA repair and aging","volume":"509","author":"Mandavilli","year":"2002","journal-title":"Mutat Res"},{"key":"10.1016\/j.aohep.2024.101774_bib0066","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1158\/0008-5472.CAN-04-2012","article-title":"Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis","volume":"65","author":"Shidara","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.aohep.2024.101774_bib0067","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1073\/pnas.0408894102","article-title":"mtDNA mutations increase tumorigenicity in prostate cancer","volume":"102","author":"Petros","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.aohep.2024.101774_bib0068","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/hmg\/ddp069","article-title":"A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis","volume":"18","author":"Park","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.aohep.2024.101774_bib0069","doi-asserted-by":"crossref","first-page":"e23401","DOI":"10.1371\/journal.pone.0023401","article-title":"Mitochondrial DNA mutations regulate metastasis of human breast cancer cells","volume":"6","author":"Imanishi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.aohep.2024.101774_bib0070","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/(SICI)1098-2264(199602)15:2<95::AID-GCC3>3.0.CO;2-Z","article-title":"Novel mitochondrial DNA deletion found in a renal cell carcinoma","volume":"15","author":"Horton","year":"1996","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.aohep.2024.101774_bib0071","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.1112125","article-title":"Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging","volume":"309","author":"Kujoth","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.aohep.2024.101774_bib0072","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1111\/bph.12431","article-title":"Cell death and the mitochondria: therapeutic targeting of the BCL-2 family-driven pathway","volume":"171","author":"Roy","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.aohep.2024.101774_bib0073","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/01.RES.0000087542.26971.D4","article-title":"Role of the mitochondrial permeability transition in myocardial disease","volume":"93","author":"Weiss","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.aohep.2024.101774_bib0074","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","article-title":"Mitochondria as multifaceted regulators of cell death","volume":"21","author":"Bock","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.aohep.2024.101774_bib0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev-physiol-021115-105045","article-title":"The biochemistry and physiology of mitochondrial fatty acid \u03b2-oxidation and its genetic disorders","volume":"78","author":"Houten","year":"2016","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.aohep.2024.101774_bib0076","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.celrep.2016.05.062","article-title":"Hepatic fatty acid oxidation restrains systemic catabolism during starvation","volume":"16","author":"Lee","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.aohep.2024.101774_bib0077","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","article-title":"Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it","volume":"6","author":"Begriche","year":"2006","journal-title":"Mitochondrion"},{"key":"10.1016\/j.aohep.2024.101774_bib0078","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.cmet.2020.10.010","article-title":"TANK-binding kinase 1 regulates the localization of acyl-CoA synthetase ACSL1 to control hepatic fatty acid oxidation","volume":"32","author":"Huh","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.aohep.2024.101774_bib0079","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1089\/ars.2021.0157","article-title":"Inhibition of fatty acid translocase (FAT\/CD36) palmitoylation enhances hepatic fatty acid \u03b2-oxidation by increasing its localization to mitochondria and interaction with long-chain acyl-coa synthetase 1","volume":"36","author":"Zeng","year":"2022","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.aohep.2024.101774_bib0080","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/hep.32148","article-title":"Therapeutic targeting of hepatic ACSL4 ameliorates NASH in mice","volume":"75","author":"Duan","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2024.101774_bib0081","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/cdd.2014.150","article-title":"Oxidative stress and autophagy: the clash between damage and metabolic needs","volume":"22","author":"Filomeni","year":"2015","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.aohep.2024.101774_bib0082","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.freeradbiomed.2013.08.174","article-title":"Free radical biology for medicine: learning from nonalcoholic fatty liver disease","volume":"65","author":"Serviddio","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.aohep.2024.101774_bib0083","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","article-title":"Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease","volume":"14","author":"Sunny","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.aohep.2024.101774_bib0084","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/gut.2007.147496","article-title":"Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury","volume":"57","author":"Serviddio","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2024.101774_bib0085","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3390\/nu11040872","article-title":"Oxidative stress and non-alcoholic fatty liver disease: effects of omega-3 fatty acid supplementation","volume":"11","author":"Yang","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.aohep.2024.101774_bib0086","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jhep.2010.09.022","article-title":"Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells","volume":"54","author":"Novo","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2024.101774_bib0087","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.taap.2009.07.021","article-title":"Troglitazone, but not rosiglitazone, damages mitochondrial DNA and induces mitochondrial dysfunction and cell death in human hepatocytes","volume":"240","author":"Rachek","year":"2009","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.aohep.2024.101774_bib0088","doi-asserted-by":"crossref","first-page":"C413","DOI":"10.1152\/ajpcell.00362.2007","article-title":"Mitochondrial DNA damage triggers mitochondrial-superoxide generation and apoptosis","volume":"294","author":"Ricci","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.aohep.2024.101774_bib0089","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1038\/s41467-020-16991-2","article-title":"Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation","volume":"11","author":"Barbier-Torres","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.aohep.2024.101774_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112435","article-title":"Organelle interactions compartmentalize hepatic fatty acid trafficking and metabolism","volume":"42","author":"Najt","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.aohep.2024.101774_bib0091","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.cmet.2018.03.003","article-title":"Mitochondria bound to lipid droplets have unique bioenergetics, composition, and dynamics that support lipid droplet expansion","volume":"27","author":"Benador","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.aohep.2024.101774_bib0092","doi-asserted-by":"crossref","first-page":"15707","DOI":"10.1074\/jbc.M110.207779","article-title":"Unique regulation of adipose triglyceride lipase (ATGL) by perilipin 5, a lipid droplet-associated protein","volume":"286","author":"Wang","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.aohep.2024.101774_bib0093","doi-asserted-by":"crossref","first-page":"12723","DOI":"10.1038\/ncomms12723","article-title":"Nuclear Perilipin 5 integrates lipid droplet lipolysis with PGC-1\u03b1\/SIRT1-dependent transcriptional regulation of mitochondrial function","volume":"7","author":"Gallardo-Montejano","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.aohep.2024.101774_bib0094","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100590","article-title":"Peridroplet mitochondria are associated with the severity of MASLD and the prevention of MASLD by diethyldithiocarbamate","volume":"65","author":"Sun","year":"2024","journal-title":"J Lipid Res"},{"key":"10.1016\/j.aohep.2024.101774_bib0095","doi-asserted-by":"crossref","first-page":"R170","DOI":"10.1016\/j.cub.2018.01.004","article-title":"Mitophagy and quality control mechanisms in mitochondrial maintenance","volume":"28","author":"Pickles","year":"2018","journal-title":"Curr Biol"},{"key":"10.1016\/j.aohep.2024.101774_bib0096","doi-asserted-by":"crossref","first-page":"736","DOI":"10.7150\/thno.79876","article-title":"Cellular mitophagy: mechanism, roles in diseases and small molecule pharmacological regulation","volume":"13","author":"Lu","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.aohep.2024.101774_bib0097","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101120","article-title":"Mst1 inhibition attenuates non-alcoholic fatty liver disease via reversing Parkin-related mitophagy","volume":"21","author":"Zhou","year":"2019","journal-title":"Redox Biol"},{"key":"10.1016\/j.aohep.2024.101774_bib0098","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1126\/science.1196371","article-title":"Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy","volume":"331","author":"Egan","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.aohep.2024.101774_bib0099","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.cmet.2018.06.014","article-title":"Mitochondrial stasis reveals p62-mediated ubiquitination in parkin-independent mitophagy and mitigates nonalcoholic fatty liver disease","volume":"28","author":"Yamada","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.aohep.2024.101774_bib0100","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s42000-019-00137-1","article-title":"Potential clinical variants detected in mitochondrial DNA d-loop hypervariable region I of patients with non-alcoholic steatohepatitis","volume":"18","author":"Hasturk","year":"2019","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.aohep.2024.101774_bib0101","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/joim.13147","article-title":"Liver mitochondrial DNA damage and genetic variability of Cytochrome b - a key component of the respirasome - drive the severity of fatty liver disease","volume":"289","author":"Pirola","year":"2021","journal-title":"J Intern Med"},{"key":"10.1016\/j.aohep.2024.101774_bib0102","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF01286409","article-title":"Outer mitochondrial membrane continuous with endoplasmic reticulum","volume":"73","author":"Franke","year":"1971","journal-title":"Protoplasma"},{"key":"10.1016\/j.aohep.2024.101774_bib0103","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0005-2760(96)00153-1","article-title":"Abnormalities in mitochondria-associated membranes and phospholipid biosynthetic enzymes in the mnd\/mnd mouse model of neuronal ceroid lipofuscinosis","volume":"1344","author":"Vance","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.aohep.2024.101774_bib0104","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/nprot.2009.151","article-title":"Isolation of mitochondria-associated membranes and mitochondria from animal tissues and cells","volume":"4","author":"Wieckowski","year":"2009","journal-title":"Nat Protoc"},{"key":"10.1016\/j.aohep.2024.101774_bib0105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.scib.2021.10.014","article-title":"Hepatic CDP-diacylglycerol synthase 2 deficiency causes mitochondrial dysfunction and promotes rapid progression of NASH and fibrosis","volume":"67","author":"Xu","year":"2022","journal-title":"Sci Bull (Beijing)"},{"key":"10.1016\/j.aohep.2024.101774_bib0106","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cell.2019.04.010","article-title":"Deficient endoplasmic reticulum-mitochondrial phosphatidylserine transfer causes liver disease","volume":"177","author":"Hern\u00e1ndez-Alvarez","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.aohep.2024.101774_bib0107","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2023.133142","article-title":"Nanoplastic propels diet-induced NAFL to NASH via ER-mitochondrial tether-controlled redox switch","volume":"465","author":"Wei","year":"2024","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.aohep.2024.101774_bib0108","doi-asserted-by":"crossref","first-page":"eaaz2841","DOI":"10.1126\/scitranslmed.aaz2841","article-title":"Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome","volume":"12","author":"Rom","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.aohep.2024.101774_bib0109","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1139\/apnm-2015-0470","article-title":"Exercise mitigates mitochondrial permeability transition pore and quality control mechanisms alterations in nonalcoholic steatohepatitis","volume":"41","author":"Gon\u00e7alves","year":"2016","journal-title":"Appl Physiol Nutr Metab"},{"key":"10.1016\/j.aohep.2024.101774_bib0110","doi-asserted-by":"crossref","first-page":"7347","DOI":"10.1073\/pnas.1922344117","article-title":"Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease","volume":"117","author":"Luukkonen","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.aohep.2024.101774_bib0111","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/gutjnl-2014-306748","article-title":"Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis","volume":"64","author":"Verbeek","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2024.101774_bib0112","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101154","article-title":"Insulin resistance is mechanistically linked to hepatic mitochondrial remodeling in non-alcoholic fatty liver disease","volume":"45","author":"Shannon","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/j.aohep.2024.101774_bib0113","doi-asserted-by":"crossref","DOI":"10.1016\/j.freeradbiomed.2013.03.022","article-title":"Role of vitamin E as a lipid-soluble peroxyl radical scavenger: in vitro and in vivo evidence","volume":"66","author":"Niki","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.aohep.2024.101774_bib0114","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3390\/ijms17121973","article-title":"Protective effects of \u03b1-tocopherol, \u03b3-tocopherol and oleic acid, three compounds of olive oils, and no effect of trolox, on 7-ketocholesterol-induced mitochondrial and peroxisomal dysfunction in microglial BV-2 cells","volume":"17","author":"Debbabi","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.aohep.2024.101774_bib0115","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1902\/jop.2013.120727","article-title":"Vitamin E supplementation, superoxide dismutase status, and outcome of scaling and root planing in patients with chronic periodontitis: a randomized clinical trial","volume":"85","author":"Singh","year":"2014","journal-title":"J Periodontol"},{"key":"10.1016\/j.aohep.2024.101774_bib0116","article-title":"Comparing palm oil, tocotrienol-rich fraction and \u03b1-tocopherol supplementation on the antioxidant levels of older adults","volume":"7","author":"Nor Azman","year":"2018","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.aohep.2024.101774_bib0117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113257","article-title":"Protective efficacy of vitamins C and E on p,p\u2019-DDT-induced cytotoxicity via the ROS-mediated mitochondrial pathway and NF-\u03baB\/FasL pathway","volume":"9","author":"Jin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.aohep.2024.101774_bib0118","article-title":"Altered mitochondrial function in masld: key features and promising therapeutic approaches","volume":"13","author":"Radosavljevic","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.aohep.2024.101774_bib0119","article-title":"Thyroid hormone receptor-beta agonist HSK31679 alleviates MASLD by modulating gut microbial sphingolipids","author":"Zhang","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2024.101774_bib0120","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(19)32517-6","article-title":"Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"394","author":"Harrison","year":"2019","journal-title":"The Lancet"},{"key":"10.1016\/j.aohep.2024.101774_bib0121","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2024.05.009","article-title":"Resmetirom for treatment of MASH","volume":"187","author":"Sookoian","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.aohep.2024.101774_bib0122","doi-asserted-by":"crossref","first-page":"60","DOI":"10.17925\/EE.2023.19.1.60","article-title":"Resmetirom: an orally administered, smallmolecule, liver-directed, \u03b2-selective THR agonist for the treatment of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"19","author":"Karim","year":"2023","journal-title":"touchREV Endocrinol"},{"key":"10.1016\/j.aohep.2024.101774_bib0123","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0022-2275(20)39682-6","article-title":"Regulation of hepatic triglyceride lipase by thyroid hormone in HepG2 cells","volume":"34","author":"Kihara","year":"1993","journal-title":"J Lipid Res"},{"key":"10.1016\/j.aohep.2024.101774_bib0124","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s42255-020-0209-6","article-title":"Resolution of NASH and hepatic fibrosis by the GLP-1R\/GcgR dual-agonist Cotadutide via modulating mitochondrial function and lipogenesis","volume":"2","author":"Boland","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.aohep.2024.101774_bib0125","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jhep.2023.07.033","article-title":"Incretins (GLP-1 receptor agonists and dual\/triple agonists) and the liver","volume":"79","author":"Newsome","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2024.101774_bib0126","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41392-023-01437-0","article-title":"Albumosomes formed by cytoplasmic pre-folding albumin maintain mitochondrial homeostasis and inhibit nonalcoholic fatty liver disease","volume":"8","author":"Ma","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.aohep.2024.101774_bib0127","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jhep.2022.03.034","article-title":"Mitochondrial protease ClpP supplementation ameliorates diet-induced NASH in mice","volume":"77","author":"Choi","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2024.101774_bib0128","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.1038\/s41467-020-19668-y","article-title":"AdipoR1\/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis","volume":"11","author":"Xu","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.aohep.2024.101774_bib0129","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1038\/s41467-022-32788-x","article-title":"Spermidine-mediated hypusination of translation factor EIF5A improves mitochondrial fatty acid oxidation and prevents non-alcoholic steatohepatitis progression","volume":"13","author":"Zhou","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.aohep.2024.101774_bib0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155663","article-title":"Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD","volume":"147","author":"Fern\u00e1ndez-S\u00e1ez","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.aohep.2024.101774_bib0131","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41401-022-00924-4","article-title":"Silybin regulates P450s activity by attenuating endoplasmic reticulum stress in mouse nonalcoholic fatty liver disease","volume":"44","author":"Wu","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.aohep.2024.101774_bib0132","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jnutbio.2015.09.015","article-title":"Astaxanthin reduces hepatic lipid accumulations in high-fat-fed C57BL\/6J mice via activation of peroxisome proliferator-activated receptor (PPAR) alpha and inhibition of PPAR gamma and Akt","volume":"28","author":"Jia","year":"2016","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.aohep.2024.101774_bib0133","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jnutbio.2016.01.006","article-title":"Astaxanthin inhibits inflammation and fibrosis in the liver and adipose tissue of mouse models of diet-induced obesity and nonalcoholic steatohepatitis","volume":"43","author":"Kim","year":"2017","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.aohep.2024.101774_bib0134","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1111\/bph.15099","article-title":"Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non-alcoholic fatty liver disease by up-regulating the FGF21\/PGC-1\u03b1 pathway","volume":"177","author":"Wu","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.aohep.2024.101774_bib0135","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.cmet.2020.04.011","article-title":"Low-dose sorafenib acts as a mitochondrial uncoupler and ameliorates nonalcoholic steatohepatitis","volume":"31","author":"Jian","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.aohep.2024.101774_bib0136","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1046130","article-title":"Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model","volume":"13","author":"Niu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.aohep.2024.101774_bib0137","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2009.11.030","article-title":"Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model","volume":"52","author":"Rector","year":"2010","journal-title":"J Hepatol"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S166526812400557X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S166526812400557X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:40:30Z","timestamp":1778622030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S166526812400557X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":137,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S166526812400557X"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101774","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms and therapeutic targets of mitochondria in the progression of metabolic dysfunction-associated steatotic liver disease","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101774","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101774"}}